Drug Resistance

Internet Tool Can Help Limit Vancomycin Use

Published in Medical Letter on the CDC and FDA, March 11th, 2001

by Julie Crawshaw, medical staff writer -- Using an Internet-based tool to evaluate vancomycin use is a good approach, but most hospital personnel in a trial program did not or could not use it, researchers say.

"Fewer than half of the personnel at hospitals completed the evaluation directly on the Internet," said R.L. Sinkowitz-Cochran and colleagues at the U.S. Department of Health and Human Services ("The Internet: A practical example of the use of new technology in the assessment of vancomycin use in pediatrics," American Journal of Infection Control, 2000;28(6):459-64).

The research team was unsure whether this was because personnel at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2001-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry